Daniel Miller

Daniel Miller

Congestive Heart Failure, or CHF, is a serious medical condition that can result in fluid buildup in the body as a result of a weak heart. When the heart can't pump enough blood to efficiently deliver nutrients and oxygen to the body, kidney function may be impaired, resulting in fluid retention. CHF patients require a broad drug regimen to maintain the delicate system balance, particularly between their heart and kidneys. These drugs include ACE inhibitors and Beta Blockers to control blood pressure, anticoagulants to prevent blood clots, and diuretics to reduce fluid overload. Many of these drugs may interact, and potential effects of these interactions must be weighed against their benefits. For this project, we consider a set of 44 drugs identified as specifically relevant for treating CHF by pediatric cardiologists at Lucile Packard Children's Hospital. This list was generated as part of our current work at the LPCH Heart Center. The goal of this project is to identify and evaluate potentially harmful drug-drug interactions (DDIs) within pediatric patients with Congestive Heart Failure. This identification will be done autonomously, so that it may continuously update by evaluating newly published literature.

Ira Kemelmacher-Shlizerman, Steve Seitz, Daniel Miller et al.

Recent face recognition experiments on a major benchmark LFW show stunning performance--a number of algorithms achieve near to perfect score, surpassing human recognition rates. In this paper, we advocate evaluations at the million scale (LFW includes only 13K photos of 5K people). To this end, we have assembled the MegaFace dataset and created the first MegaFace challenge. Our dataset includes One Million photos that capture more than 690K different individuals. The challenge evaluates performance of algorithms with increasing numbers of distractors (going from 10 to 1M) in the gallery set. We present both identification and verification performance, evaluate performance with respect to pose and a person's age, and compare as a function of training data size (number of photos and people). We report results of state of the art and baseline algorithms. Our key observations are that testing at the million scale reveals big performance differences (of algorithms that perform similarly well on smaller scale) and that age invariant recognition as well as pose are still challenging for most. The MegaFace dataset, baseline code, and evaluation scripts, are all publicly released for further experimentations at: megaface.cs.washington.edu.

D. Miller, E. Brossard, S. Seitz et al.

Recent face recognition experiments on the LFW benchmark show that face recognition is performing stunningly well, surpassing human recognition rates. In this paper, we study face recognition at scale. Specifically, we have collected from Flickr a \textbf{Million} faces and evaluated state of the art face recognition algorithms on this dataset. We found that the performance of algorithms varies--while all perform great on LFW, once evaluated at scale recognition rates drop drastically for most algorithms. Interestingly, deep learning based approach by \cite{schroff2015facenet} performs much better, but still gets less robust at scale. We consider both verification and identification problems, and evaluate how pose affects recognition at scale. Moreover, we ran an extensive human study on Mechanical Turk to evaluate human recognition at scale, and report results. All the photos are creative commons photos and is released at \small{\url{http://megaface.cs.washington.edu/}} for research and further experiments.